Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Multicenter Study
. 2014 Dec;134(12):3000-3003.
doi: 10.1038/jid.2014.272. Epub 2014 Jul 7.

Primary Melanoma Tumors From CDKN2A Mutation Carriers Do Not Belong to a Distinct Molecular Subclass

Affiliations
Free article
Multicenter Study

Primary Melanoma Tumors From CDKN2A Mutation Carriers Do Not Belong to a Distinct Molecular Subclass

Johan Staaf et al. J Invest Dermatol. .
Free article

Similar articles

  • Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study.
    Zebary A, Omholt K, van Doorn R, Ghiorzo P, Harbst K, Hertzman Johansson C, Höiom V, Jönsson G, Pjanova D, Puig S, Scarra GB, Harland M, Olsson H, Egyhazi Brage S, Palmer J, Kanter-Lewensohn L, Vassilaki I, Hayward NK, Newton-Bishop J, Gruis NA, Hansson J; Melanoma Genetics Consortium (GenoMEL). Zebary A, et al. J Invest Dermatol. 2014 Jan;134(1):287-290. doi: 10.1038/jid.2013.270. Epub 2013 Jun 14. J Invest Dermatol. 2014. PMID: 23771122 No abstract available.
  • Longitudinal assessment of the nevus phenotype in a melanoma kindred.
    Florell SR, Meyer LJ, Boucher KM, Porter-Gill PA, Hart M, Erickson J, Cannon-Albright LA, Pershing LK, Harris RM, Samlowski WE, Zone JJ, Leachman SA. Florell SR, et al. J Invest Dermatol. 2004 Sep;123(3):576-82. doi: 10.1111/j.0022-202X.2004.23312.x. J Invest Dermatol. 2004. PMID: 15304099
  • Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium. Demenais F, et al. J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28. J Natl Cancer Inst. 2010. PMID: 20876876 Free PMC article. Clinical Trial.
  • Melanoma: What do all the mutations mean?
    Davis EJ, Johnson DB, Sosman JA, Chandra S. Davis EJ, et al. Cancer. 2018 Sep 1;124(17):3490-3499. doi: 10.1002/cncr.31345. Epub 2018 Apr 17. Cancer. 2018. PMID: 29663336 Free PMC article. Review.
  • B-RAF and melanocytic neoplasia.
    Gill M, Celebi JT. Gill M, et al. J Am Acad Dermatol. 2005 Jul;53(1):108-14. doi: 10.1016/j.jaad.2005.04.013. J Am Acad Dermatol. 2005. PMID: 15965430 Review.
See all similar articles

Cited by 1 article

References

    1. Nature. 2002 Jun 27;417(6892):949-54 - PubMed
    1. N Engl J Med. 2005 Nov 17;353(20):2135-47 - PubMed
    1. Oncogene. 2003 May 19;22(20):3053-62 - PubMed
    1. J Invest Dermatol. 2014 Jan;134(1):287-90 - PubMed
    1. Clin Cancer Res. 2012 Aug 1;18(15):4026-36 - PubMed

MeSH terms

LinkOut - more resources

Feedback